Linlin Guo is a Principal Scientist at AbbVie, focusing on informatics in Immuno-Oncology preclinical and clinical development since January 2023. Previously, Guo served as the Lead Data Scientist at Kronos Bio, where contributions were made to the Lanra SYK clinical drug pipeline. Prior experience includes a role as Senior Investment Manager at Viva Biotech, overseeing due diligence and industry reports for venture capital investments. Guo also held the position of Scientist II at PACT Pharma, managing single-cell RNA deep sequencing projects, and began a career at Genentech as Scientist I, working on biomarker discovery in rheumatoid arthritis. Linlin Guo holds a PhD in Genetics and Genomics from the University of Rochester and is a candidate for an M.S. in Immunology and Virology from Tsinghua University.
This person is not in any teams
This person is not in any offices